T20 Pill: yellow, oval, 13mm

Viagra > yellow viagra pill


The rate and extent of absorption of tadalafil are not influenced by food; thus tadalafil may be taken with or without food. Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues.

  • The yellow Viagra pill has become a well-known symbol in ED treatment discussions.
  • It may interact with certain herbal supplements, altering its effects.
  • Not for use in women, children, or individuals without erectile dysfunction.
  • Side effects commonly occur, but serious reactions are rare with proper use.
  • The pill’s popularity has led to numerous imitations, emphasizing the need for caution.
  • Always check medication information and consult medical professionals before use.

Metabolism — Tadalafil is predominantly metabolized by CYP3A4 to a catechol metabolite.

  • There are various brands producing yellow Viagra pills, with slight ingredient variations.
  • The pill can sometimes be identified by its specific shape and markings.
  • Regular monitoring by a healthcare provider is recommended during treatment.
  • Viagra's molecular structure is designed to target specific enzymes related to erections.
  • Consumers should beware of unverified sources selling cheap or suspicious yellow pills.
  • Proper use and adherence to prescribed doses maximize safety and effectiveness.

Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects. Geriatric — Healthy male elderly subjects (65 years or over) had a lower oral clearance of tadalafil, resulting in 25% higher exposure (AUC) with no effect on Cmax relative to that observed in healthy subjects 19 to 45 years of age. Patients with Diabetes Mellitus — In male patients with diabetes mellitus after a 10 mg tadalafil dose, exposure (AUC) was reduced approximately 19% and Cmax was 5% lower than that observed in healthy subjects. Patients with BPH — In patients with BPH following single and multiple-doses of 20 mg tadalafil, no statistically significant differences in exposure (AUC and Cmax) were observed between elderly (70 to 85 years) and younger (≤ 60 years of age) subjects.

Risks and warnings for Tadalafil (Cialis)

13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of FertilityCarcinogenesis — Tadalafil was not carcinogenic to rats or mice when administered daily for 2 years at doses up to 400 mg/kg/day.

Product Dosage Quantity + Bonus Price
Viagra Original100mg12 Pills72.54€ 69.09€
Viagra Generic150mg30 + 2 Pills72.32€ 68.88€
Viagra Super Active100mg360 + 30 Pills470.93€ 448.50€
Viagra Oral Jelly100mg21 Sachets78.66€ 74.91€
Viagra Super Active100mg30 + 6 Pills64.09€ 61.04€
Viagra Oral Jelly100mg10 Sachets46.36€ 44.15€
Viagra Professional100mg30 Pills88.92€ 84.69€
Viagra Original100mg64 + 4 Pills264.15€ 251.57€
Viagra Original100mg14 + 2 Pills89.03€ 84.79€
Viagra Original100mg120 + 8 Pills470.39€ 447.99€
Viagra Professional100mg10 Pills44.09€ 41.99€
Viagra Soft Tabs100mg90 + 6 Pills205.31€ 195.53€
Viagra Professional100mg120 + 4 Pills262.83€ 250.31€
Viagra Original100mg48 + 4 Pills207.15€ 197.29€

Systemic drug exposures, as measured by AUC of unbound tadalafil, were approximately 10-fold for mice, and 14- and 26-fold for male and female rats, respectively, the exposures in human males given Maximum Recommended Human Dose (MRHD) of 20 mg.Mutagenesis — Tadalafil was not mutagenic in the in vitro bacterial Ames assays or the forward mutation test in mouse lymphoma cells. Tadalafil was not clastogenic in the in vitro chromosomal aberration test in human lymphocytes or the in vivo rat micronucleus assays.Impairment of Fertility — There were no effects on fertility, reproductive performance or reproductive organ morphology in male or female rats given oral doses of tadalafil up to 400 mg/kg/day, a dose producing AUCs for unbound tadalafil of 14-fold for males or 26-fold for females the exposures observed in human males given the MRHD of 20 mg. In beagle dogs given tadalafil daily for 3 to 12 months, there was treatment-related non-reversible degeneration and atrophy of the seminiferous tubular epithelium in the testes in 20% to 100% of the dogs that resulted in a decrease in spermatogenesis in 40% to 75% of the dogs at doses of ≥ 10 mg/kg/day. In dogs, an increased incidence of disseminated arteritis was observed in 1- and 6-month studies at unbound tadalafil exposure of 1- to 54-fold above the human exposure (AUC) at the MRHD of 20 mg. Carcinogenesis — Tadalafil was not carcinogenic to rats or mice when administered daily for 2 years at doses up to 400 mg/kg/day. Mutagenesis — Tadalafil was not mutagenic in the in vitro bacterial Ames assays or the forward mutation test in mouse lymphoma cells.

Brand Manufacturer Price Range (per pill) Availability Notes
Pfizer Viagra Pfizer Inc. $15 - $30 Widely available Original brand
YellowPower Generic Labs $5 - $10 Online pharmacies Generic version
MaxiYellow HealthCorp $8 - $18 Pharmacies Alternative brand

Impairment of Fertility — There were no effects on fertility, reproductive performance or reproductive organ morphology in male or female rats given oral doses of tadalafil up to 400 mg/kg/day, a dose producing AUCs for unbound tadalafil of 14-fold for males or 26-fold for females the exposures observed in human males given the MRHD of 20 mg. 14 CLINICAL STUDIES 14.1 Tadalafil Tablets for Use as Needed for EDThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials of up to 24-weeks duration, involving over 4,000 patients. Tadalafil, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).Tadalafil was studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, tadalafil was taken as needed, at doses ranging from 2.5 mg to 20 mg, up to once buy soft viagra per day. Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of tadalafil on erectile function.

User Experience Satisfaction Level Comments
John D. Improved performance 4/5 Works well, fast action
Mike S. Mild side effects 3/5 Effective but slight headache
Alan P. Quick onset 5/5 Very effective, no issues
David L. Not effective 2/5 Did not see desired results

SEP Question 2 asks, “Were you able to insert your penis into the partner’s vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials — The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). Most (> 90%) patients reported ED of at least 1-year duration.

  • The yellow Viagra pill may have a logo, company name, or unique markings.
  • It is part of a class of drugs called phosphodiesterase inhibitors.
  • Side effects vary but can include dizziness, upset stomach, or visual disturbances.
  • Do not use if you have severe liver or kidney problems without medical advice.
  • Always discuss current health and medications with your healthcare provider before use.
  • The pill should be used strictly as part of a prescribed treatment plan.

In each of these 2 trials, tadalafil 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Table 11).

3. Back pain

The results demonstrated a difference between the placebo group and the tadalafil group at each of the pre-specified timepoints. At the 24-hour timepoint, (more specifically, 22 to 26 hours), 53/144 (37%) patients reported at least 1 successful intercourse in the placebo group versus 84/138 (61%) in the tadalafil 20-mg group. At the 36-hour timepoint (more specifically, 33 to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the tadalafil 20-mg group.In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, tadalafil 10 mg, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 and 36 hours post-dosing).

Recreational use

Common Searches for Imprint

The treatment effect of tadalafil did not diminish over time.Table 11: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in the Two Primary US TrialsResults in General ED Population in Trials Outside the US — The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1,112 patients, with a mean age of 59 years (range 21 to 82 years). In these 5 trials, tadalafil 5 mg, 10 mg, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Tables 12, 13 and 14).

How much does Sildenafil (Viagra) cost?

The rate and extent of absorption of tadalafil are not influenced by food; thus tadalafil may be taken with or without food. Distribution — The mean apparent volume of distribution following oral administration is approximately 63 L, indicating that tadalafil is distributed into tissues. Metabolism — Tadalafil is predominantly metabolized by CYP3A4 to a catechol metabolite. Excretion — The mean oral clearance for tadalafil is 2.5 L/hr and the mean terminal half-life is 17.5 hours in healthy subjects. Geriatric — Healthy male elderly subjects (65 years or over) had a lower oral clearance of tadalafil, resulting in 25% higher exposure (AUC) with no effect on Cmax relative to that observed in healthy subjects 19 to 45 years of age.

Marketing and sales

Patients with Diabetes Mellitus — In male patients with diabetes mellitus after a 10 mg tadalafil dose, exposure (AUC) was reduced approximately 19% and Cmax was 5% lower than that observed in healthy subjects. Patients with BPH — In patients with BPH following single and multiple-doses of 20 mg tadalafil, no statistically significant differences in exposure (AUC and Cmax) were observed between elderly (70 to 85 years) and younger (≤ 60 years of age) subjects. 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of FertilityCarcinogenesis — Tadalafil was not carcinogenic to rats or mice when administered daily for 2 years at doses up to 400 mg/kg/day. Systemic drug exposures, as measured by AUC of unbound tadalafil, were approximately 10-fold for mice, and 14- and 26-fold for male and female rats, respectively, the exposures in human males given Maximum Recommended Human Dose (MRHD) of 20 mg.Mutagenesis — Tadalafil was not mutagenic in the in vitro bacterial Ames assays or the forward mutation test in mouse lymphoma cells. Tadalafil was not clastogenic in the in vitro chromosomal aberration test in human lymphocytes or the in vivo rat micronucleus assays.Impairment of Fertility — There were no effects on fertility, reproductive performance or reproductive organ morphology in male or female rats given oral doses of tadalafil up to 400 mg/kg/day, a dose producing AUCs for unbound tadalafil of 14-fold for males or 26-fold for females the exposures observed in human males given the MRHD of 20 mg.

Jet lag research

In beagle dogs given tadalafil daily for 3 to 12 months, there was treatment-related non-reversible degeneration and atrophy of the seminiferous tubular epithelium in the testes in 20% to 100% of the dogs that resulted in a decrease in spermatogenesis in 40% to 75% of the dogs at doses of ≥ 10 mg/kg/day. In dogs, an increased incidence of disseminated arteritis was observed in 1- and 6-month studies at unbound tadalafil exposure of 1- to 54-fold above the human exposure (AUC) at the MRHD of 20 mg. Carcinogenesis — Tadalafil was not carcinogenic to rats or mice when administered daily for 2 years at doses up to 400 mg/kg/day. Mutagenesis — Tadalafil was not mutagenic in the in vitro bacterial Ames assays or the forward mutation test in mouse lymphoma cells. Impairment of Fertility — There were no effects on fertility, reproductive performance or reproductive organ morphology in male or female rats given oral doses of tadalafil up to 400 mg/kg/day, a dose producing AUCs for unbound tadalafil of 14-fold for males or 26-fold for females the exposures observed in human males given the MRHD of 20 mg. The treatment effect of tadalafil did not diminish over time.Table 12: Mean Endpoint and Change from Baseline for the EF Domain of the IIEF in the General ED Population in Five Primary Trials Outside the USTable 13: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 2 (“Were you able to insert your penis into the partner’s vagina?”) in the General ED Population in Five Pivotal Trials Outside the USTable 14: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 3 (“Did your erection last long enough for you to have successful intercourse?”) in the General ED Population in Five Pivotal Trials Outside the USIn addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking tadalafil, compared to patients on placebo.Therefore, in all 7 primary efficacy and safety studies, tadalafil showed statistically significant improvement in patients’ ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries.Efficacy Results in ED Patients with Diabetes Mellitus — Tadalafil was shown to be effective in treating ED in patients with diabetes mellitus. Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed tadalafil in ED patients with type 1 or type 2 diabetes (N=216).

7.1 Potential for Pharmacodynamic Interactions with Tadalafil Tablets

Does tadalafil interact with foods or drinks?

In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, tadalafil demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 15).Table 15: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in ED Patients with DiabetesEfficacy Results in ED Patients following Radical Prostatectomy — Tadalafil was shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy. In 1 randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial in this population (N=303), tadalafil demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 16).Table 16: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in Patients who Developed ED Following Bilateral Nerve-Sparing Radical ProstatectomyResults in Studies to Determine the Optimal Use of Tadalafil — Several studies were conducted with the objective of determining the optimal use of tadalafil in the treatment of ED. In this randomized, placebo-controlled, double-blinded trial, 223 patients were randomized to placebo, tadalafil 10 mg, or 20 mg. At or prior to 30 minutes, 35% (26/74), 38% (28/74), and 52% (39/75) of patients in the placebo, 10-mg, and 20-mg groups, respectively, reported successful erections as defined above.Two studies were conducted to assess the efficacy of tadalafil at a given timepoint after dosing, specifically at 24 hours and at 36 hours after dosing.In the first of these studies, 348 patients with ED were randomized to placebo or tadalafil 20 mg.

Key takeaways:

The results demonstrated a difference between the placebo group and the tadalafil group at each of the pre-specified timepoints. At the 24-hour timepoint, (more specifically, 22 to 26 hours), 53/144 (37%) patients reported at least 1 successful intercourse in the placebo group versus 84/138 (61%) in the tadalafil 20-mg group. At the 36-hour timepoint (more specifically, 33 to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the tadalafil 20-mg group.In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, tadalafil 10 mg, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 and 36 hours post-dosing).

What does Cialis look like?

14 CLINICAL STUDIES 14.1 Tadalafil Tablets for Use as Needed for EDThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials of up to 24-weeks duration, involving over 4,000 patients. Tadalafil, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).Tadalafil was studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, tadalafil was taken as needed, at doses ranging from 2.5 mg to 20 mg, up to once buy soft viagra per day. Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of tadalafil on erectile function. SEP Question 2 asks, “Were you able to insert your penis into the partner’s vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials — The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years).

Are you currently using Tadalafil (Cialis, Adcirca, and others)?

Most (> 90%) patients reported ED of at least 1-year duration. In each of these 2 trials, tadalafil 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Table 11). The treatment effect of tadalafil did not diminish over time.Table 11: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in the Two Primary US TrialsResults in General ED Population in Trials Outside the US — The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1,112 patients, with a mean age of 59 years (range 21 to 82 years). In these 5 trials, tadalafil 5 mg, 10 mg, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Tables 12, 13 and 14). The treatment effect of tadalafil did not diminish over time.Table 12: Mean Endpoint and Change from Baseline for the EF Domain of the IIEF in the General ED Population in Five Primary Trials Outside the USTable 13: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 2 (“Were you able to insert your penis into the partner’s vagina?”) in the General ED Population in Five Pivotal Trials Outside the USTable 14: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 3 (“Did your erection last long enough for you to have successful intercourse?”) in the General ED Population in Five Pivotal Trials Outside the USIn addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking tadalafil, compared to patients on placebo.Therefore, in all 7 primary efficacy and safety studies, tadalafil showed statistically significant improvement in patients’ ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries.Efficacy Results in ED Patients with Diabetes Mellitus — Tadalafil was shown to be effective in treating ED in patients with diabetes mellitus.

What does TADALAFIL (Generic for ADCIRCA) look like?

Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed tadalafil in ED patients with type 1 or type 2 diabetes (N=216). In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, tadalafil demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 15).Table 15: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in ED Patients with DiabetesEfficacy Results in ED Patients following Radical Prostatectomy — Tadalafil was shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy. In 1 randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial in this population (N=303), tadalafil demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 16).Table 16: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in Patients who Developed ED Following Bilateral Nerve-Sparing Radical ProstatectomyResults in Studies to Determine the Optimal Use of Tadalafil — Several studies were conducted with the objective of determining the optimal use of tadalafil in the treatment of ED. In this randomized, placebo-controlled, double-blinded trial, 223 patients were randomized to placebo, tadalafil 10 mg, or 20 mg. At or prior to 30 minutes, 35% (26/74), 38% (28/74), and 52% (39/75) of patients in the placebo, 10-mg, and 20-mg groups, respectively, reported successful erections as defined above.Two studies were conducted to assess the efficacy of tadalafil at a given timepoint after dosing, specifically at 24 hours and at 36 hours after dosing.In the first of these studies, 348 patients with ED were randomized to placebo or tadalafil 20 mg.